Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation

Fig. 2

Rosiglitazone promoted the migration of HUVECs. a and b Cell migration was assessed by a wound healing assay. Representative micrographs at × 400 magnification (a) and the distance moved of cells (b) without or with rosiglitazone (1, 5, or 10 μM) for 24 h are shown. c and d Cell migration was assessed by a Transwell migration assay. Representative micrographs at × 400 magnification (c) and the number of cells that moved without or with rosiglitazone (1, 5, or 10 μM) for 24 h are shown. Data are represented as % of control. (n = 4; * p < 0.01 compared with control)

Back to article page
\